Provides eligible, commercially insured patients with assistance to pay for their Celltrion medicines up to $0 out of pocket per each prescription. Terms and conditions apply*

Patients who are uninsured, underinsured, or lack coverage may be eligible to receive VEGZELMA® (bevacizumab-adcd) at no cost. Patient eligibiliy criteria, including household income limits, and program terms and conditions apply*. Celltrion CONNECT® can help evaluate patients’ eligibility for assistance.